Gilbert and Helmer focus their practices on corporate finance transactions, mergers and acquisitions, technology transfers and licensing, corporate governance and securities law compliance with an emphasis in the technology, life sciences and energy industries.
Roger Meltzer, partner and global chair of the corporate and finance practice at DLA Piper, commented on the move in a firm press release.
“The pharmaceutical, life sciences and technology markets in New Jersey, New York and Pennsylvania are strategic priorities for the firm, and the additions of Andrew and Michael bolster the firm’s capabilities to address the constantly increasing needs of clients in these sectors.”
DLA Piper has 3,500 lawyers in 30 countries and 68 offices throughout the US, UK, Continental Europe, Middle East and Asia.